Corrigendum to “Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors” [Eur. J. Med. Chem. (2023), 251, 115237]

IF 5.9 2区 医学 Q1 CHEMISTRY, MEDICINAL European Journal of Medicinal Chemistry Pub Date : 2025-07-05 Epub Date: 2025-04-14 DOI:10.1016/j.ejmech.2025.117581
Kaifu Wu , Rui He , Zongyang Li , Kongxi Qiu , Guorong Xiao , Lijie Peng , Xiangbao Meng , Canhui Zheng , Zhang Zhang , Qian Cai
{"title":"Corrigendum to “Discovery of 3,5-diaryl-1H-pyrazol-based ureas as potent RET inhibitors” [Eur. J. Med. Chem. (2023), 251, 115237]","authors":"Kaifu Wu , Rui He , Zongyang Li , Kongxi Qiu , Guorong Xiao , Lijie Peng , Xiangbao Meng , Canhui Zheng , Zhang Zhang , Qian Cai","doi":"10.1016/j.ejmech.2025.117581","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"291 ","pages":"Article 117581"},"PeriodicalIF":5.9000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425003460","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
“发现以3,5-二芳基- 1h -吡唑为基础的尿素作为有效的RET抑制剂”的勘误表[欧元]。医学化学。(2023), 251, 115237]
作者感到遗憾的是,在最初的起草过程中,图5中的蛋白质条带无意中错位,导致了SHC蛋白质条带的重复。下载:下载高分辨率图片(844KB)下载:下载全尺寸图片5. 在原稿中(红框内的带子抄错了)。下载:下载高分辨率图片(853KB)下载:下载全尺寸图片5. 纠正了图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
期刊最新文献
Discovery of novel covalent agonists for p53 Y220C through synergistic strategy combining covalent binding and scaffold hopping Novel methoxyquinazoline sulfonamide derivatives as angiogenesis inhibitors and radiosensitizers Rational design and synthesis of flavonolactam derivatives as potent topo I inhibitors with antitumor activity Porphyrins modified fibroblast activation protein inhibitor for enhanced cancer radionuclide therapy Novel design of interleukin-2 derivatives with reversed pH and potent antitumor activity
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1